Cannabinoids, Blood-Brain Barrier, and Brain Disposition
Blood-brain barrier disturbances in diabetes-associated dementia
Methods for delivery of drugs across the bloodbrain barrier
Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist
Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Inhibiting Oxidative Stress and ASK1-p38 Signaling
Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling
the "entourage effect"
This web site is not a commercial web site and is presented for educational purposes only.
Copyright © Lawrence Turner
All Rights Reserved